<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-id journal-id-type="publisher-id">Arq. Bras. Cardiol.</journal-id><journal-title-group><journal-title>Arquivos brasileiros de cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24553982</article-id><article-id pub-id-type="pmc">3987318</article-id><article-id pub-id-type="doi">10.5935/abc.20140003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Echocardiographic Parameters and Survival in Chagas Heart Disease with
Severe Systolic Dysfunction</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rassi</surname><given-names>Daniela do Carmo</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>Vieira</surname><given-names>Marcelo Luiz Campos</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Arruda</surname><given-names>Ana L&#x000fa;cia Martins</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Hotta</surname><given-names>Viviane Tiemi</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Furtado</surname><given-names>Rog&#x000e9;rio Gomes</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Rassi</surname><given-names>Danilo Teixeira</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Rassi</surname><given-names>Salvador</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib></contrib-group><aff id="aff01"><label>1</label> Faculdade de Medicina e Hospital das Cl&#x000ed;nicas da Universidade Federal
de Goi&#x000e1;s (UFG), Goi&#x000e2;nia, GO - Brazil </aff><aff id="aff02"><label>2</label> Instituto do Cora&#x000e7;&#x000e3;o da Faculdade de Medicina da Universidade de S&#x000e3;o
Paulo (USP), S&#x000e3;o Paulo, SP - Brazil </aff><aff id="aff03"><label>3</label> Instituto de Radiologia da Faculdade de Medicina da Universidade de S&#x000e3;o
Paulo (USP), S&#x000e3;o Paulo, SP - Brazil </aff><author-notes><corresp id="c01"><bold>Mailing address: Daniela do Carmo Rassi</bold>, Rua 1, n&#x000fa;mero 352, apto 901,
Edif&#x000ed;cio Reserva dos Buritis, Setor Oeste. Postal Code 74115-040, Goi&#x000e2;nia, GO -
Brazil. E-mail: <email>dani.rassi@hotmail.com</email>,
<email>danirassi@cardiol.br</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2014</year></pub-date><volume>102</volume><issue>3</issue><fpage>245</fpage><lpage>252</lpage><history><date date-type="received"><day>22</day><month>5</month><year>2013</year></date><date date-type="rev-recd"><day>13</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2013</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p></license></permissions><abstract><sec><title>Background</title><p>Echocardiography provides important information on the cardiac evaluation of
patients with heart failure. The identification of echocardiographic parameters in
severe Chagas heart disease would help implement treatment and assess prognosis.
</p></sec><sec><title>Objective</title><p>To correlate echocardiographic parameters with the endpoint cardiovascular
mortality in patients with ejection fraction &#x0003c; 35%. </p></sec><sec><title>Methods</title><p>Study with retrospective analysis of pre-specified echocardiographic parameters
prospectively collected from 60 patients included in the Multicenter Randomized
Trial of Cell Therapy in Patients with Heart Diseases (Estudo Multic&#x000ea;ntrico
Randomizado de Terapia Celular em Cardiopatias) - Chagas heart disease arm. The
following parameters were collected: left ventricular systolic and diastolic
diameters and volumes; ejection fraction; left atrial diameter; left atrial
volume; indexed left atrial volume; systolic pulmonary artery pressure; integral
of the aortic flow velocity; myocardial performance index; rate of increase of
left ventricular pressure; isovolumic relaxation time; E, A, Em, Am and Sm wave
velocities; E wave deceleration time; E/A and E/Em ratios; and mitral
regurgitation. </p></sec><sec><title>Results</title><p>In the mean 24.18-month follow-up, 27 patients died. The mean ejection fraction
was 26.6 &#x000b1; 5.34%. In the multivariate analysis, the parameters ejection fraction
(HR = 1.114; p = 0.3704), indexed left atrial volume (HR = 1.033; p &#x0003c; 0.0001)
and E/Em ratio (HR = 0.95; p = 0.1261) were excluded. The indexed left atrial
volume was an independent predictor in relation to the endpoint, and values &#x0003e;
70.71 mL/m<sup>2</sup> were associated with a significant increase in mortality
(log rank p &#x0003c; 0.0001). </p></sec><sec><title>Conclusion</title><p>The indexed left atrial volume was the only independent predictor of mortality in
this population of Chagasic patients with severe systolic dysfunction.</p></sec></abstract><kwd-group><kwd>Echocardiography / diagnosis</kwd><kwd>Survivorship (Public Health)</kwd><kwd>Chagas Cardiomyopathy</kwd><kwd>Chagas Disease</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>One hundred years after been first described, Chagas disease remains a serious health
and economic problem in most countries in Latin America. Ten million people are
estimated to be infected worldwide, most of them in Latin America, where the disease is
endemic. More than 25 million people are at risk for the disease. Chagas disease has
killed more than 10 thousand people according to an estimate made in 2008<sup><xref rid="r01" ref-type="bibr">1</xref></sup>.</p><p>This parasitic disease is transmitted to man by means of infected feces of hematophagous
insects in endemic areas and, occasionally, by blood transfusion. Its diagnosis is made
based on a history suggestive of contact and on two or more positive specific
serological tests<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup>.</p><p>Chagas disease has two phases: the acute and chronic phases. The acute phase commonly
manifests as a self limited febrile syndrome lasting for 2 to 8 weeks, with clinical
symptoms in less than 1% of patients. In the chronic phase, approximately half of these
patients remain in the indeterminate form, which has low mortality and a good prognosis,
whereas the other half progresses to the chronic form, with cardiac and/or digestive
impairment 10 to 30 years after the initial infection<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup>.</p><p>The cardiac form is the most common and severe manifestation of Chagas disease in its
chronic phase. The myocardial abnormalities in the chronic phase are extremely variable,
ranging from mild forms, such as digitiform apical aneurysms and abnormalities of the
left ventricular diastolic function only, to significant cardiac chamber dilatation,
with severe systolic dysfunction<sup><xref rid="r05" ref-type="bibr">5</xref>-<xref rid="r08" ref-type="bibr">8</xref></sup>.</p><p>Echocardiogram is a well-established test in the clinical practice and provides
parameters by which chagasic patients can be analyzed and stratified. In our study,
patients with severe systolic dysfunction, who already have a poor prognosis, were
analyzed. The objective was to identify markers of a poor prognosis that would help us
start a more aggressive and optimized treatment in an attempt to improve the unfavorable
outcome of these patients<sup><xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup>.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Population and study site</title><p>This is a study with retrospective analysis of pre-specified data collected
prospectively from patients included in the Multicenter Randomized Trial of Cell
Therapy in Heart Diseases (<italic>Estudo Multic&#x000ea;ntrico Randomizado de Terapia
Celular em Cardiopatias -</italic> EMRTCC) - Chagas heart disease arm, conducted
from February 2006 to February 2009. The EMRTCC was a prospective randomized double
blind study, which, in our Institution, had a sample of 60 patients with severe
systolic dysfunction (ejection fraction - EF &#x0003c; 35%) and NYHA functional classes
III and IV. The exclusion criteria were: heart valve diseases, except for functional
tricuspid or mitral regurgitation; coronary arteriography showing significant lesion
(obstruction of 50% or more in one or more coronary artery); presence of a
functioning implantable cardioverter/defibrillator; diseases that could impact the
life expectancy or any other comorbidity impacting on the 2-year survival; and
echocardiographic images inappropriate for a correct interpretation. The
echocardiographic measurements were performed when the patients were randomized. At
that moment, optimization of the medical treatment had been achieved, and the
patients were hemodynamically stable. The result of the EMRTCC - Chagas heart disease
arm, did not show elevation of the EF in the group receiving stem cell implantation,
and the population of 60 patients was considered homogeneous, with no influence of
the intervention between the two groups<sup><xref rid="r11" ref-type="bibr">11</xref></sup>.</p><p>The primary endpoint of our study was defined as cardiovascular mortality.
Cardiovascular mortality was considered as sudden death, when occurring less than 1
hour after the change in symptoms, or as death for progressive worsening of heart
failure, when resulting from worsening of symptoms or previous hemodynamic
deterioration.</p><p>The study was conducted in the Clinics Hospital of the Federal University of Goi&#x000e1;s
(HC-UFG). The patients were selected from the heart failure outpatient clinic of the
institution. Clinical assessments and follow-up of these patients were carried out in
this outpatient clinic. Echocardiography was performed in the imaging service of the
institution. The project was approved by the Scientific and Ethics Commission of
HC-UFG, and the patients gave written informed consent.</p></sec><sec><title>Echocardiographic assessment</title><p>Echocardiograms were performed in a Xsario ultrasound scanner (Toshiba) available in
the department of echocardiography of HC-UFG, with images digitally recorded. Images
were obtained according to the criteria established by the American Society of
Echocardiography (ASE)<sup><xref rid="r12" ref-type="bibr">12</xref></sup>. All tests
were performed by one single highly experienced examiner duly trained to obtain the
parameters measured, and in one single scanner of the institution.</p><p>The following parameters of the echocardiographic study were assessed: left
ventricular end-diastolic diameter (LVEDD) and LV end-systolic diameter (LVESD); LV
end diastolic volume (LVEDV) and LV end-systolic volume (LVESV); EF as estimated by
the Simpson's method; left atrial diameter (LA); LA volume (LAV); LAV indexed for
body surface (LAV/m<sup>2</sup>); pulmonary artery systolic pressure (PASP); integral
of the aortic flow velocity (IFV Ao); derivative of pressure/derivative of time
(dP/dT); isovolumic relaxation time (IVRT); myocardial performance index (MPI); E and
A wave velocities (by pulsed Doppler); E/A ratio and E wave deceleration time (DCT);
myocardial tissue velocity of Em, Am and Sm waves (by tissue Doppler in the basal
segment of the inferoseptal wall); and E/Em wave ratio.</p></sec><sec><title>Statistical analysis</title><p>The survival curves were calculated using the Kapplan-Meier product-limit method, and
compared using the log-rank test. Survival probabilities were estimated with a 95%
confidence interval (CI). Quantitative variables were dichotomized using the optimal
cut-off point obtained from the ROC (Receiver Operating Characteristic) analyses.
Non-adjusted and adjusted hazard ratios (HR) with 95% CI were estimated in the Cox
univariate and multivariate regression analyses, respectively. The multiple
regression model used the proportion of number of events per variable of 9:1, with
confirmed balanced estimates. Normality of variables was assessed using the
Kolmogorov-Smirnov test, and were represented as mean &#x000b1; standard deviation or median
and 95% CI, depending on a normal or non-normal distribution, respectively. All
probabilities of significance (p values) presented are two-sided and values &#x0003c; 0.05
were considered statistically significant. P values between 0.05 and 0.10 were
interpreted as marginally significant. The statistical analysis of data was carried
out using the Stata 11 (Stata Corp, College Station, TX) and SAS 9.2 (Statistical
Analysis System, Cary, NC) software programs.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Clinical and echocardiographic characteristics of the study group are shown in <xref ref-type="table" rid="t01">Tables 1</xref> and <xref ref-type="table" rid="t02">2</xref>, respectively.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical characteristics of the group</p></caption><table frame="hsides" rules="rows"><thead><tr><td rowspan="1" colspan="1">
<bold>Characteristic</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Mean &#x000b1; SD</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">50.9 &#x000b1; 9.3</td></tr><tr><td rowspan="1" colspan="1">Gender (%)</td><td align="center" rowspan="1" colspan="1">n = 60</td></tr><tr><td rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">70</td></tr><tr><td rowspan="1" colspan="1">Drug therapy (%)</td><td align="center" rowspan="1" colspan="1">n = 60</td></tr><tr><td rowspan="1" colspan="1">Diuretics</td><td align="center" rowspan="1" colspan="1">88.3</td></tr><tr><td rowspan="1" colspan="1">ACEI</td><td align="center" rowspan="1" colspan="1">60</td></tr><tr><td rowspan="1" colspan="1">ARB</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td rowspan="1" colspan="1">Betablocker</td><td align="center" rowspan="1" colspan="1">60</td></tr><tr><td rowspan="1" colspan="1">Spironolactone</td><td align="center" rowspan="1" colspan="1">85</td></tr><tr><td rowspan="1" colspan="1">Digoxin</td><td align="center" rowspan="1" colspan="1">61</td></tr><tr><td rowspan="1" colspan="1">Amiodarone</td><td align="center" rowspan="1" colspan="1">58.33</td></tr><tr><td rowspan="1" colspan="1">Rhythm in atrial fibrilation (%)</td><td align="center" rowspan="1" colspan="1">6.6</td></tr><tr><td rowspan="1" colspan="1">Pacemaker (%)</td><td align="center" rowspan="1" colspan="1">30</td></tr></tbody></table><table-wrap-foot><fn><p>SD: standard deviation; ACEI: angiotensin converting enzyme inhibitor; ARB:
angiotensin II receptor blocker.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><p>Echocardiographic characteristics of the group</p></caption><table frame="hsides" rules="rows"><thead><tr><td rowspan="2" colspan="1">
<bold>Variable</bold>
</td><td rowspan="2" align="center" colspan="1">
<bold>p (KS)</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">
<bold>Parameters</bold>
</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">
<bold>Mean &#x000b1; SD</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Median</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>95% CI</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">EF (%)</td><td align="center" rowspan="1" colspan="1">0.617</td><td align="center" rowspan="1" colspan="1">26.7 &#x000b1; 5.3</td><td align="center" rowspan="1" colspan="1">27.4</td><td align="center" rowspan="1" colspan="1">25.3 - 28.1</td></tr><tr><td rowspan="1" colspan="1">LVEDD (mm)</td><td align="center" rowspan="1" colspan="1">0.667</td><td align="center" rowspan="1" colspan="1">78.9 &#x000b1; 8.7</td><td align="center" rowspan="1" colspan="1">78.6</td><td align="center" rowspan="1" colspan="1">76.7 - 81.2</td></tr><tr><td rowspan="1" colspan="1">LVESD (mm)</td><td align="center" rowspan="1" colspan="1">0.485</td><td align="center" rowspan="1" colspan="1">67.4 &#x000b1; 8.0</td><td align="center" rowspan="1" colspan="1">67.3</td><td align="center" rowspan="1" colspan="1">65.3 - 69.5</td></tr><tr><td rowspan="1" colspan="1">LVEDV (mL)</td><td align="center" rowspan="1" colspan="1">0.724</td><td align="center" rowspan="1" colspan="1">271.3 &#x000b1; 94.5</td><td align="center" rowspan="1" colspan="1">265.6</td><td align="center" rowspan="1" colspan="1">246.9 - 295.7</td></tr><tr><td rowspan="1" colspan="1">LVESV (mL)</td><td align="center" rowspan="1" colspan="1">0.855</td><td align="center" rowspan="1" colspan="1">189.3 &#x000b1; 73.0</td><td align="center" rowspan="1" colspan="1">186.8</td><td align="center" rowspan="1" colspan="1">170.5 - 208.2</td></tr><tr><td rowspan="1" colspan="1">LA (mm)</td><td align="center" rowspan="1" colspan="1">0.833</td><td align="center" rowspan="1" colspan="1">48.3 &#x000b1; 8.5</td><td align="center" rowspan="1" colspan="1">48.0</td><td align="center" rowspan="1" colspan="1">46.1 - 50.5</td></tr><tr><td rowspan="1" colspan="1">LAV (mL)</td><td align="center" rowspan="1" colspan="1">0.375</td><td align="center" rowspan="1" colspan="1">104.9 &#x000b1; 42.3</td><td align="center" rowspan="1" colspan="1">98.7</td><td align="center" rowspan="1" colspan="1">93.9 - 115.8</td></tr><tr><td rowspan="1" colspan="1">LAV/m<sup>2</sup> (ml/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">0.330</td><td align="center" rowspan="1" colspan="1">62.9 &#x000b1; 24.4</td><td align="center" rowspan="1" colspan="1">58.8</td><td align="center" rowspan="1" colspan="1">56.6 - 69.2</td></tr><tr><td rowspan="1" colspan="1">PASP (mmHg)</td><td align="center" rowspan="1" colspan="1">0.022<sup><xref ref-type="table-fn" rid="t02-fn01">*</xref></sup>
</td><td align="center" rowspan="1" colspan="1">38.1 &#x000b1; 13.4</td><td align="center" rowspan="1" colspan="1">33.6</td><td align="center" rowspan="1" colspan="1">34.3 - 41.9</td></tr><tr><td rowspan="1" colspan="1">IFV Ao (cm)</td><td align="center" rowspan="1" colspan="1">0.002<sup><xref ref-type="table-fn" rid="t02-fn01">*</xref></sup>
</td><td align="center" rowspan="1" colspan="1">13.2 &#x000b1; 8.7</td><td align="center" rowspan="1" colspan="1">12.0</td><td align="center" rowspan="1" colspan="1">10.9 - 15.5</td></tr><tr><td rowspan="1" colspan="1">DCT (ms)</td><td align="center" rowspan="1" colspan="1">0.122</td><td align="center" rowspan="1" colspan="1">188.0 &#x000b1; 92.3</td><td align="center" rowspan="1" colspan="1">160.0</td><td align="center" rowspan="1" colspan="1">164.2 - 211.8</td></tr><tr><td rowspan="1" colspan="1">MPI</td><td align="center" rowspan="1" colspan="1">0.026<sup><xref ref-type="table-fn" rid="t02-fn01">*</xref></sup>
</td><td align="center" rowspan="1" colspan="1">0.89 &#x000b1; 0.40</td><td align="center" rowspan="1" colspan="1">0.82</td><td align="center" rowspan="1" colspan="1">0.79 - 0.99</td></tr><tr><td rowspan="1" colspan="1">dP/dT</td><td align="center" rowspan="1" colspan="1">0.286</td><td align="center" rowspan="1" colspan="1">489.6 &#x000b1; 162.3</td><td align="center" rowspan="1" colspan="1">444.0</td><td align="center" rowspan="1" colspan="1">447.7 - 531.5</td></tr><tr><td rowspan="1" colspan="1">IVRT (ms)</td><td align="center" rowspan="1" colspan="1">0.005<sup><xref ref-type="table-fn" rid="t02-fn01">*</xref></sup>
</td><td align="center" rowspan="1" colspan="1">116.9 &#x000b1; 72.1</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">98.3 - 135.6</td></tr><tr><td rowspan="1" colspan="1">A (cm/s)</td><td align="center" rowspan="1" colspan="1">0.426</td><td align="center" rowspan="1" colspan="1">46.8 &#x000b1; 23.3</td><td align="center" rowspan="1" colspan="1">41.3</td><td align="center" rowspan="1" colspan="1">40.5 - 53.1</td></tr><tr><td rowspan="1" colspan="1">E (cm/s)</td><td align="center" rowspan="1" colspan="1">0.522</td><td align="center" rowspan="1" colspan="1">63.9 &#x000b1; 25.0</td><td align="center" rowspan="1" colspan="1">61.4</td><td align="center" rowspan="1" colspan="1">57.5 - 70.4</td></tr><tr><td rowspan="1" colspan="1">Am (cm/s)</td><td align="center" rowspan="1" colspan="1">0.853</td><td align="center" rowspan="1" colspan="1">4.8 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">4.3 - 5.4</td></tr><tr><td rowspan="1" colspan="1">Em (cm/s)</td><td align="center" rowspan="1" colspan="1">0.395</td><td align="center" rowspan="1" colspan="1">4.8 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">4.5</td><td align="center" rowspan="1" colspan="1">4.4 - 5.3</td></tr><tr><td rowspan="1" colspan="1">Sm (cm/s)</td><td align="center" rowspan="1" colspan="1">0.774</td><td align="center" rowspan="1" colspan="1">4.6 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">4.7</td><td align="center" rowspan="1" colspan="1">4.3 - 4.9</td></tr></tbody></table><table-wrap-foot><fn id="t02-fn01"><label>*</label><p> Signifcant: variables statistically significant. HR: hazard ratio; 95% CI: 95%
confidence interval; EF: ejection fraction; LVEDD: left ventricular
end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LVEDV:
left ventricular end-diastolic volume; LVESV: left ventricular end-systolic
volume; LA: left atrial anteroposterior measurement; LAV: left atrial volume;
LAV/m<sup>2</sup>: left atrial volume indexed for body surface; PASP:
pulmonary artery systolic pressure; IFV Ao: integral of the aortic flow
velocity; DCT: E wave deceleration time; MPI: myocardial performance index;
dP/dT: derivative of the pressure/derivative of time; IVRT: isovolumic
relaxation time; A: transmitral flow velocity of late ventricular filling; E:
transmitral flow velocity of early ventricular filling; E/A: E and A wave
ratio; Em and Am: diastolic tissue velocities; Sm: systolic tissue velocity;
E/Em: E and Em wave ratio; MR 1 vs. 2: mild versus moderate mitral
regurgitation.</p></fn></table-wrap-foot></table-wrap><p>Cardiovascular deaths occurred in 27 (45%) of the 60 patients in a mean follow-up of 24
months (<xref ref-type="fig" rid="f01">Figure 1</xref>). All remained with optimized
drug therapy and did not receive resynchronization therapy or implantable
cardio-defibrillator during the follow-up.</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Kapplan-Meier curve with analysis of overall survival in the study population</p></caption><graphic xlink:href="abc-102-03-0245-g01"/></fig><sec><title>Analysis of the echocardiographic parameters</title><p>The association between the echocardiographic parameters and the endpoint was
initially assessed by univariate analysis (<xref ref-type="table" rid="t03">Table
3</xref>).</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 3</label><caption><p>Univariate analysis of predictors of cardiovascular events</p></caption><table frame="hsides" rules="rows"><thead><tr><td align="center" rowspan="1" colspan="1">
<bold>Parameter</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>n</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Events</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>HR</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Lowest 95%CI</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Highest 95%CI</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>p value</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">EF</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">0.932</td><td align="center" rowspan="1" colspan="1">0.873</td><td align="center" rowspan="1" colspan="1">0.994</td><td align="center" rowspan="1" colspan="1">0.031<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">LVEDD</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.036</td><td align="center" rowspan="1" colspan="1">0.988</td><td align="center" rowspan="1" colspan="1">1.087</td><td align="center" rowspan="1" colspan="1">0.1464</td></tr><tr><td rowspan="1" colspan="1">LVESD</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">2.573</td><td align="center" rowspan="1" colspan="1">0.972</td><td align="center" rowspan="1" colspan="1">6.81</td><td align="center" rowspan="1" colspan="1">0.057</td></tr><tr><td rowspan="1" colspan="1">LVEDV</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.005</td><td align="center" rowspan="1" colspan="1">1.001</td><td align="center" rowspan="1" colspan="1">1.009</td><td align="center" rowspan="1" colspan="1">0.0275<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">LVESV</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.005</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.01</td><td align="center" rowspan="1" colspan="1">0.0403<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">LA</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.064</td><td align="center" rowspan="1" colspan="1">1.021</td><td align="center" rowspan="1" colspan="1">1.109</td><td align="center" rowspan="1" colspan="1">0.0031<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">LAV</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.015</td><td align="center" rowspan="1" colspan="1">1.008</td><td align="center" rowspan="1" colspan="1">1.021</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.0001<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">LAV/m<sup>2</sup>
</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">1.036</td><td align="center" rowspan="1" colspan="1">1.021</td><td align="center" rowspan="1" colspan="1">1.051</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.0001<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">PASP</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.039</td><td align="center" rowspan="1" colspan="1">1.012</td><td align="center" rowspan="1" colspan="1">1.067</td><td align="center" rowspan="1" colspan="1">0.0039<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">IFV Ao</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">0.947</td><td align="center" rowspan="1" colspan="1">0.852</td><td align="center" rowspan="1" colspan="1">1.053</td><td align="center" rowspan="1" colspan="1">0.3151</td></tr><tr><td rowspan="1" colspan="1">DCT</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">0.993</td><td align="center" rowspan="1" colspan="1">0.987</td><td align="center" rowspan="1" colspan="1">0.998</td><td align="center" rowspan="1" colspan="1">0.0093<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">MPI</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">2.423</td><td align="center" rowspan="1" colspan="1">1.032</td><td align="center" rowspan="1" colspan="1">5.689</td><td align="center" rowspan="1" colspan="1">0.0421<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">dP/dT</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.998</td><td align="center" rowspan="1" colspan="1">1.003</td><td align="center" rowspan="1" colspan="1">0.7342</td></tr><tr><td rowspan="1" colspan="1">IVRT</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">0.997</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">1.004</td><td align="center" rowspan="1" colspan="1">0.3499</td></tr><tr><td rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">0.976</td><td align="center" rowspan="1" colspan="1">0.956</td><td align="center" rowspan="1" colspan="1">0.996</td><td align="center" rowspan="1" colspan="1">0.0212<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">E</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.029</td><td align="center" rowspan="1" colspan="1">1.013</td><td align="center" rowspan="1" colspan="1">1.046</td><td align="center" rowspan="1" colspan="1">0.0004<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">E/A</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">1.589</td><td align="center" rowspan="1" colspan="1">1.205</td><td align="center" rowspan="1" colspan="1">2.096</td><td align="center" rowspan="1" colspan="1">0.001<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">Am</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">0.847</td><td align="center" rowspan="1" colspan="1">0.687</td><td align="center" rowspan="1" colspan="1">1.044</td><td align="center" rowspan="1" colspan="1">0.1192</td></tr><tr><td rowspan="1" colspan="1">Em</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.003</td><td align="center" rowspan="1" colspan="1">0.805</td><td align="center" rowspan="1" colspan="1">1.249</td><td align="center" rowspan="1" colspan="1">0.9815</td></tr><tr><td rowspan="1" colspan="1">Sm</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">0.726</td><td align="center" rowspan="1" colspan="1">0.514</td><td align="center" rowspan="1" colspan="1">1.026</td><td align="center" rowspan="1" colspan="1">0.07<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">E/ EM</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.083</td><td align="center" rowspan="1" colspan="1">1.019</td><td align="center" rowspan="1" colspan="1">1.151</td><td align="center" rowspan="1" colspan="1">0.0104<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">MR 1 vs. 2</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">0.325</td><td align="center" rowspan="1" colspan="1">0.146</td><td align="center" rowspan="1" colspan="1">0.728</td><td align="center" rowspan="1" colspan="1">0.0063<sup><xref ref-type="table-fn" rid="t03-fn01">*</xref></sup>
</td></tr></tbody></table><table-wrap-foot><fn id="t03-fn01"><label>*</label><p> Signifcant: variables statistically significant. HR: hazard ratio; 95% CI:
95% confidence interval; EF: ejection fraction; LVEDD: left ventricular
end-diastolic diameter; LVESD: left ventricular end-systolic diameter;
LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular
end-systolic volume; LA: left atrial anteroposterior measurement; LAV left
atrial volume; LAV/m': left atrial volume indexed for body surface; PASP:
pulmonary artery systolic pressure; IFV Ao: integral of the aortic flow
velocity; DCT E wave deceleration time; MPI: myocardial performance index;
dP/dT: derivative of the pressure/derivative of time; IVRT: isovolumic
relaxation time; A: transmitral flow velocity of late ventricular filling;
E: transmitral flow velocity of early ventricular filling; E/A: E and A wave
ratio; Em and Am: diastolic tissue velocities; Sm: systolic tissue velocity;
E/Em: E and Em wave ratio; MR 1 vs. 2: mild versus moderate mitral
regurgitation.</p></fn></table-wrap-foot></table-wrap><p>Based on the clinical relevance and aiming to include anatomical and functional data,
three echocardiographic parameters were selected for the multivariate analysis (<xref ref-type="table" rid="t04">Table 4</xref>).</p><table-wrap id="t04" orientation="portrait" position="float"><label>Table 4</label><caption><p>Multivariate analysis of predictors of cardiovascular events</p></caption><table frame="hsides" rules="rows"><thead><tr><td rowspan="1" colspan="1">
<bold>Parameter</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Regression coefficient (beta)</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>HR</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Lowest 95%CI</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Highest 95%CI</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>p value</bold>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">EF </td><td align="center" rowspan="1" colspan="1">-0.0508945</td><td align="center" rowspan="1" colspan="1">0.95</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">1.014</td><td align="center" rowspan="1" colspan="1">0.1261</td></tr><tr><td rowspan="1" colspan="1">LAV/m2 </td><td align="center" rowspan="1" colspan="1">0.0321653</td><td align="center" rowspan="1" colspan="1">1.033</td><td align="center" rowspan="1" colspan="1">1.017</td><td align="center" rowspan="1" colspan="1">1.049</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.0001<sup><xref ref-type="table-fn" rid="t04-fn01">*</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">E/Em </td><td align="center" rowspan="1" colspan="1">0.0337537</td><td align="center" rowspan="1" colspan="1">1.034</td><td align="center" rowspan="1" colspan="1">0.961</td><td align="center" rowspan="1" colspan="1">1.114</td><td align="center" rowspan="1" colspan="1">0.3704</td></tr></tbody></table><table-wrap-foot><fn id="t04-fn01"><label>*</label><p> Signifcant: variables statistically significant. HR: risk ratio; 95% CI:
95% confidence interval; EF: ejection fraction; LAV/m<sup>2</sup>: left
atrial volume indexed for body surface; E/Em: E (transmitral flow velocity
of filling) and Em (diastolic tissue velocity) wave ratio.</p></fn></table-wrap-foot></table-wrap><p>Among the parameters assessed, only LAV/m<sup>2</sup> proved to be an independent
predictor in relation to the endpoint.</p><p>When an LAV/m<sup>2</sup> value of 70.71 mL/m<sup>2</sup> was obtained, a larger
distance between the study population was observed in relation to the endpoint
mortality (<xref ref-type="fig" rid="f02">Figure 2</xref>), with an area under the
curve of 0.827 (95% CI = 0.708 - 0.913) (<xref ref-type="fig" rid="f03">Figure
3</xref>).</p><fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Relationship between survival and Indexed Left Atrial Volume (LAV
/m<sup>2</sup>)</p></caption><graphic xlink:href="abc-102-03-0245-g02"/></fig><fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><p>ROC curve of the indexed left atrial volume</p></caption><graphic xlink:href="abc-102-03-0245-g03"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Most of the echocardiographic studies involving patients with chronic chagasic
cardiomyopathy sought to correlate echocardiographic parameters with survival, using
proportional hazards models (Cox models). The populations assessed in these studies had
varying expressions of the disease ranging from no cardiac impairment to severe disease
with significant symptoms. In our study, exclusively patients presenting with severe
structural cardiac involvement and significant systolic dysfunction were
selected<sup><xref rid="r10" ref-type="bibr">10</xref></sup>.</p><p>Our results did not demonstrate a correlation between increased left ventricular
diastolic and systolic diameters and decreased survival rates. This is consistent with
Bestetti et al<sup><xref rid="r13" ref-type="bibr">13</xref></sup>, Viotti et
al<sup><xref rid="r14" ref-type="bibr">14</xref></sup>, and Salles et al<sup><xref rid="r15" ref-type="bibr">15</xref></sup> findings. Evidences of segmental or
global wall motion abnormalities and increased LVEDD significantly correlated with the
endpoint mortality in a retrospective cohort of 424 patients evaluated by Rassi et
al<sup><xref rid="r16" ref-type="bibr">16</xref></sup>. We may have not confirmed
these findings in our cohort because it was comprised of patients with severe systolic
dysfunction and segmental or global wall motion abnormalities invariably present, unlike
Rassi's cohort<sup><xref rid="r16" ref-type="bibr">16</xref></sup>. Increases in LVEDV
and LVESV, as well as decrease in EF, correlated with the survival rate in the
univariate analysis of this group of patients; however this was not confirmed in the
multivariate analysis<sup><xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r16" ref-type="bibr">16</xref></sup>.</p><p>The variable most commonly described as an independent predictor of death among the
studies previously conducted is EF. This variable assesses the left ventricular systolic
function and may be obtained by echocardiography using different methods. Several
studies have evaluated the impact of the decrease in EF in relation to the survival of
chagasic patients. In a meta-analysis of six echocardiographic series involving 3,135
patients, Aquatella<sup><xref rid="r10" ref-type="bibr">10</xref></sup> clearly
demonstrated these findings.</p><p>Specifically, in the series involving chagasic patients with severe heart failure, the
only echocardiographic finding that proved to be statistically significant among
survivors, in the multivariate analysis, was the decrease in left ventricular EF (LVEF).
The first of them was conducted by Mady et al<sup><xref rid="r17" ref-type="bibr">17</xref></sup>, in which 104 patients in functional class from II to IV were
assessed, with a 50% mortality in a 47-month follow-up. The second was conducted by
Bestetti et al<sup><xref rid="r13" ref-type="bibr">13</xref></sup>, in which 56 patients
in functional classes III and IV were evaluated, with a 28% mortality in a 24-month
follow-up. </p><p>In another study conducted in the modern era of the treatment for heart disease,
Theodoropoulos et al<sup><xref rid="r18" ref-type="bibr">18</xref></sup> evaluated 127
patients diagnosed with systolic heart failure secondary to chagasic cardiomyopathy and
observed that LVEF, as well as the use of betablockers, digoxin, serum sodium level, and
functional class IV on admission were independent predictors of mortality in a mean
25-month follow-up<sup><xref rid="r18" ref-type="bibr">18</xref></sup>.</p><p>The right ventricular systolic function was not assessed in our study, because it was
part of the echocardiographic parameters of the protocol established by EMRTCC. However,
we should point out that the presence of right ventricular systolic dysfunction is also
an independent predictor of mortality in chagasic cardiomyopathy, as demonstrated by
Nunes et al<sup><xref rid="r19" ref-type="bibr">19</xref></sup> in a study of 158
patients and a mean 34-month follow-up, in which this parameter was assessed using the
Tei index.</p><p>In our study, there was a significant correlation of the anteroposterior LA diameter,
LAV, and LAV/m<sup>2</sup> with the survival rate of these patients. LAV/m<sup>2</sup>
was the only echocardiographic parameter in the multivariate analysis that proved to be
an independent predictor of cardiovascular mortality in this population. When obtained,
using an optimal cut-off point of 70.71 mL/m<sup>2</sup> by means of the ROC analysis,
we observed an area under the curve of 0.827 (95% CI = 0.708 - 0.913).</p><p>These results corroborate those of a recent study conducted by Nunes et al<sup><xref rid="r20" ref-type="bibr">20</xref></sup>, who evaluated 192 chagasic patients
retrospectively in a follow-up of 33.8 months. The authors showed that the increase in
LAV/m<sup>2</sup> is an independent predictor of cardiovascular mortality (HR = 1.037
mL/m<sup>2</sup>) and increments the value of other parameters such as EF and
Doppler-derived measurements in the assessment of diastole<sup><xref rid="r20" ref-type="bibr">20</xref></sup>.</p><p>LAV abnormalities also have an impact on the survival in heart diseases of other causes,
such as ischemic heart disease. M&#x000f8;ller et al<sup><xref rid="r21" ref-type="bibr">21</xref></sup> followed up 314 patients for a mean of 15 months and showed that
LAV mL/m<sup>2</sup> &#x0003e; 32 mL/m<sup>2</sup> was an important predictor of mortality,
even after adjustment for clinical factors, systolic function, and Doppler-derived
parameters of diastolic function<sup><xref rid="r21" ref-type="bibr">21</xref></sup>.</p><p>As for patients with severe systolic dysfunction, Rossi et al<sup><xref rid="r22" ref-type="bibr">22</xref></sup> conducted a meta-analysis with 1157 patients from 18
studies on heart failure and demonstrated than increased LA area was associated with a
worse prognosis, regardless of age, NYHA functional class, EF, or restrictive filling
pattern<sup><xref rid="r22" ref-type="bibr">22</xref></sup>.</p><p>In our group of patients, no statistically significant correlation was demonstrated
between Em and Am wave velocity abnormalities and survival. There was a tendency for a
correlation between Sm wave and survival rate (p = 0.07). Tissue velocities were
evaluated in the inferoseptal wall (basal segment); many chagasic patients may show
greater impairment in this region, as well as in the basal segment of the inferior and
inferolateral wall and apex. Perhaps the most appropriate site for these measurements is
another wall, where the probability of segmental impairment is lower. Another factor
that may have compromised our tissue parameters was that approximately 30% of patients
used pacemakers and 6.6% had rhythm in atrial fibrillation. These factors also
compromise tissue assessment during diastole.</p><sec><title>Limitation</title><p>This was a study of retrospective analysis of data prospectively collected, and this
implies in limitations inherent to this type of analysis.</p><p>There was no sample calculation for the analysis of endpoints, because the cohort
available was of 60 patients. This limits possible additional conclusions, because of
the small number of primary endpoint (mortality).</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Increased indexed left atrial volume proved to be the only echocardiographic parameter
to independently correlate with cardiovascular mortality in this population of severely
ill chagasic patients.</p></sec></body><back><fn-group><fn fn-type="conflict"><p>
<bold>Potential Conflict of Interest</bold>
</p><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="other"><p>
<bold>Study Association</bold>
</p><p>This article is part of the thesis of master submitted by Daniela do Carmo Rassi from
Faculdade de Medicina da Universidade Federal de Goi&#x000e1;s (UFG).</p></fn><fn fn-type="financial-disclosure"><p>
<bold>Sources of Funding</bold>
</p><p>This study was funded by FINEP.</p></fn><fn fn-type="con"><p><bold>Author contributions</bold></p><p>Conception and design of the research: Rassi DC, Vieira MLC, Arruda ALM, Furtado RG,
Rassi DT, Rassi S; Acquisition of data: Rassi DC, Rassi DT, Rassi S; Analysis and
interpretation of the data, Critical revision of the manuscript for intellectual
content and Writing of the manuscript: Rassi DC, Vieira MLC, Arruda ALM, Hotta VT,
Furtado RG, Rassi DT, Rassi S; Statistical analysis: Rassi DC, Vieira MLC, Arruda
ALM, Hotta VT, Furtado RG, Rassi S; Obtaining funding: Rassi S.</p></fn></fn-group><ref-list><title>References</title><ref id="r01"><label>1</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Weekly epidemiological record. Relev&#x000e9; &#x000e9;pid&#x000e9;miologique hebdomadaire
[internet]</source><date-in-citation content-type="access-date">Cited in 2013 Jun
2013</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/wer">http://www.who.int/wer</ext-link></comment></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Storino</surname><given-names>R</given-names></name></person-group><article-title>Non-invasive studies</article-title><person-group person-group-type="author"><name><surname>Storino</surname><given-names>R</given-names></name><name><surname>Milei</surname><given-names>J</given-names></name></person-group><source>Enfermedad de Chagas</source><publisher-loc>Buenos Aires</publisher-loc><publisher-name>Doyma Argentina</publisher-name><fpage>359</fpage><lpage>454</lpage><year>1994</year></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maguire</surname><given-names>JH</given-names></name><name><surname>Hoff</surname><given-names>R</given-names></name><name><surname>Sherlock</surname><given-names>I</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>AC</given-names></name><name><surname>Sleigh</surname><given-names>AC</given-names></name><name><surname>Ramos</surname><given-names>NB</given-names></name><etal>et al</etal></person-group><article-title>Cardiac morbidity and mortality due to Chagas disease: prospective
electrocardiographic study of a Brazilian community</article-title><source>Circulation</source><year>1987</year><volume>75</volume><issue>6</issue><fpage>1140</fpage><lpage>1145</lpage><pub-id pub-id-type="pmid">3552307</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>E</given-names></name><name><surname>Laranja</surname><given-names>FS</given-names></name><name><surname>Miranda</surname><given-names>A</given-names></name><name><surname>Nobrega</surname><given-names>G</given-names></name></person-group><article-title>Chagas' disease: a clinical, epidemiologic, and pathologic
study</article-title><source>Circulation</source><year>1956</year><volume>14</volume><issue>6</issue><fpage>1035</fpage><lpage>1060</lpage><pub-id pub-id-type="pmid">13383798</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ianni</surname><given-names>BM</given-names></name><name><surname>Arteaga</surname><given-names>E</given-names></name><name><surname>Frimm</surname><given-names>CC</given-names></name><name><surname>Pereira Barretto</surname><given-names>AC</given-names></name><name><surname>Mady</surname><given-names>C</given-names></name></person-group><article-title>Chagas' heart disease: evolutive evaluation of electrocardiographic
and echocardiographic parameters in patients with the indeterminate
form</article-title><source>Arq Bras Cardiol</source><year>2001</year><volume>77</volume><issue>1</issue><fpage>59</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">11500748</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migliore</surname><given-names>RA</given-names></name><name><surname>Adaniya</surname><given-names>ME</given-names></name><name><surname>Tamagusuku</surname><given-names>H</given-names></name><name><surname>Lapuente</surname><given-names>A</given-names></name></person-group><article-title>Assessment of diastolic function in Chagas disease with pulsed Doppler
tissue imaging</article-title><source>Arch Cardiol Mex</source><year>2004</year><volume>74</volume><issue>1</issue><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">15125264</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acquatella</surname><given-names>H</given-names></name></person-group><article-title>Present situation of Chagas disease in Venezuela and therapeutic
management</article-title><source>Gac Med Caracas</source><year>2003</year><volume>111</volume><fpage>136</fpage><lpage>156</lpage></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camara</surname><given-names>EJ</given-names></name></person-group><trans-title>Segmental changes in contractility of the left heart ventricle in Chagas
cardiomyopathy with and without ventricular dilatation</trans-title><source>Arq Bras Cardiol</source><year>1993</year><volume>60</volume><issue>3</issue><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">8250743</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassi</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Rassi</surname><given-names>A</given-names></name><name><surname>Rassi</surname><given-names>SG</given-names></name></person-group><article-title>Predictors of mortality in chronic Chagas disease: a systematic review
of observational studies</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>9</issue><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="pmid">17339568</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acquatella</surname><given-names>H</given-names></name></person-group><article-title>Echocardiography in Chagas heart disease</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>9</issue><fpage>1124</fpage><lpage>1131</lpage><pub-id pub-id-type="pmid">17339570</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro dos Santos</surname><given-names>RR</given-names></name><name><surname>Rassi</surname><given-names>S</given-names></name><name><surname>Feitosa</surname><given-names>G</given-names></name><name><surname>Grecco</surname><given-names>OT</given-names></name><name><surname>Rassi</surname><given-names>A Jr</given-names></name><name><surname>Cunha</surname><given-names>AB</given-names></name><etal>et al</etal></person-group><article-title>Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter
randomized trial of cell therapy in cardiopathies study): a multicenter randomized
trial</article-title><source>Circulation</source><year>2012</year><volume>125</volume><issue>20</issue><fpage>2254</fpage><lpage>2261</lpage></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>RM</given-names></name><name><surname>Bierig</surname><given-names>M</given-names></name><name><surname>Devereux</surname><given-names>RB</given-names></name><name><surname>Flachskampf</surname><given-names>FA</given-names></name><name><surname>Foster</surname><given-names>E</given-names></name><name><surname>Pellikka</surname><given-names>PA</given-names></name><etal>et al</etal></person-group><article-title>Chamber Quantification Writing Group; American Society of
Echocardiography's Guidelines and Standards Committee. Recommendations for chamber
quantification: a report from the American Society of Echocardiography's
Guidelines and Standards Committee and the Chamber Quantification Writing Group,
developed in conjunction with the European Association of Echocardiography, a
branch of the European Society of Cardiology</article-title><source>J Am Soc Echocardiogr</source><year>2005</year><volume>18</volume><issue>12</issue><fpage>1440</fpage><lpage>1463</lpage><pub-id pub-id-type="pmid">16376782</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bestetti</surname><given-names>RB</given-names></name><name><surname>Dalbo</surname><given-names>CM</given-names></name><name><surname>Freitas</surname><given-names>OC</given-names></name><name><surname>Teno</surname><given-names>LA</given-names></name><name><surname>Castilho</surname><given-names>OT</given-names></name><name><surname>Oliveira</surname><given-names>JS</given-names></name></person-group><article-title>Noninvasive predictors of mortality for patients with Chagas' heart
disease: a multivariate stepwise logistic regression study</article-title><source>Cardiology</source><year>1994</year><volume>84</volume><issue>4-5</issue><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">8187110</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viotti</surname><given-names>RJ</given-names></name><name><surname>Vigliano</surname><given-names>C</given-names></name><name><surname>Laucella</surname><given-names>S</given-names></name><name><surname>Lococo</surname><given-names>B</given-names></name><name><surname>Petti</surname><given-names>M</given-names></name><name><surname>Bertocchi</surname><given-names>G</given-names></name><etal>et al</etal></person-group><article-title>Value of echocardiography for diagnosis and prognosis of chronic
Chagas disease cardiomyopathy without heart failure</article-title><source>Heart</source><year>2004</year><volume>90</volume><issue>6</issue><fpage>655</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">15145872</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salles</surname><given-names>G</given-names></name><name><surname>Xavier</surname><given-names>S</given-names></name><name><surname>Sousa</surname><given-names>A</given-names></name><name><surname>Hasslocher-Moreno</surname><given-names>A</given-names></name><name><surname>Cardoso</surname><given-names>C</given-names></name></person-group><article-title>Prognostic value of QT interval parameters for mortality risk
stratification in Chagas' disease: results of a long-term follow-up
study</article-title><source>Circulation</source><year>2003</year><volume>108</volume><issue>3</issue><fpage>305</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">12835217</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassi</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Rassi</surname><given-names>A</given-names></name><name><surname>Little</surname><given-names>WC</given-names></name><name><surname>Xavier</surname><given-names>SS</given-names></name><name><surname>Rassi</surname><given-names>SG</given-names></name><name><surname>Rassi</surname><given-names>AG</given-names></name><etal>et al</etal></person-group><article-title>Development and validation of a risk score for predicting mortality in
Chagas'heart disease</article-title><source>N Engl J Med</source><year>2006</year><volume>355</volume><issue>8</issue><fpage>799</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">16928995</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mady</surname><given-names>C</given-names></name><name><surname>Cardoso</surname><given-names>RH</given-names></name><name><surname>Barretto</surname><given-names>AC</given-names></name><name><surname>da Luz</surname><given-names>PL</given-names></name><name><surname>Bellotti</surname><given-names>G</given-names></name><name><surname>Pileggi</surname><given-names>F</given-names></name></person-group><article-title>Survival and predictors of survival in patients with congestive heart
failure due to Chagas' cardiomyopathy</article-title><source>Circulation</source><year>1994</year><volume>90</volume><issue>6</issue><fpage>3098</fpage><lpage>3102</lpage><pub-id pub-id-type="pmid">7994859</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theodoropoulos</surname><given-names>TA</given-names></name><name><surname>Bestetti</surname><given-names>RB</given-names></name><name><surname>Otaviano</surname><given-names>AP</given-names></name><name><surname>Cordeiro</surname><given-names>JA</given-names></name><name><surname>Rodrigues</surname><given-names>VC</given-names></name><name><surname>Silva</surname><given-names>AC</given-names></name></person-group><article-title>Predictors of all-cause mortality in chronic Chagas&#x000b4; disease in the
current era of heart failure therapy</article-title><source>Int J Cardiol</source><year>2008</year><volume>128</volume><issue>1</issue><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">18258318</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>MC</given-names></name><name><surname>Rocha</surname><given-names>MO</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Colosimo</surname><given-names>EA</given-names></name><name><surname>Rezende</surname><given-names>RA</given-names></name><name><surname>Carmo</surname><given-names>GA</given-names></name><etal>et al</etal></person-group><article-title>Right ventricular dysfunction is an independent predictor of survival
in patients with dilated chronic Chagas' cardiomyopathy</article-title><source>Int J Cardiol</source><year>2008</year><volume>127</volume><issue>3</issue><fpage>372</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">17689706</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>MC</given-names></name><name><surname>Barbosa</surname><given-names>MM</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Colosimo</surname><given-names>EA</given-names></name><name><surname>Rocha</surname><given-names>MO</given-names></name></person-group><article-title>Left atrial volume provides independent prognostic value in patients
with Chagas cardiomyopathy</article-title><source>J Am Soc Echocardiogr</source><year>2009</year><volume>22</volume><issue>1</issue><fpage>82</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">19131007</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000f8;ller</surname><given-names>JE</given-names></name><name><surname>Hillis</surname><given-names>GS</given-names></name><name><surname>Oh</surname><given-names>JK</given-names></name><name><surname>Seward</surname><given-names>JB</given-names></name><name><surname>Reeder</surname><given-names>GS</given-names></name><name><surname>Scott</surname><given-names>R</given-names></name><etal>et al</etal></person-group><article-title>Left atrial volume: a powerful predictor of survival after acute
myocardial infarction</article-title><source>Circulation</source><year>2003</year><volume>107</volume><issue>17</issue><fpage>2207</fpage><lpage>2212</lpage><pub-id pub-id-type="pmid">12695291</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Temporelli</surname><given-names>PG</given-names></name><name><surname>Quintana</surname><given-names>M</given-names></name><name><surname>Dini</surname><given-names>FL</given-names></name><name><surname>Ghio</surname><given-names>S</given-names></name><name><surname>Hillis</surname><given-names>GS</given-names></name><etal>et al</etal></person-group><article-title>Independent relationship of left atrial size and mortality in patients
with heart failure: an individual patient meta-analysis of longitudinal data
(MeRGE Heart Failure)</article-title><source>Eur J Heart Fail</source><year>2009</year><volume>11</volume><issue>10</issue><fpage>929</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">19789395</pub-id></element-citation></ref></ref-list></back></article>